… concern regarding potential effects of ovulation-inducing drugs on cancer risk. First, the … for
stimulating ovulation, a factor implicated in the etiology of both breast and ovarian cancers (3, …

… may seem encouraging, because of the small numbers of patients actually undergoing
ovulation induction, this study has thus far failed to adequately assess the population most at risk. …

… support an increased risk of ovarian cancer following ovulation induction in parous women.
… between treatment for ovulation induction and overall risk of cancer, particularly cancer of the …

… that nulliparity might have explained the increased risk of ovarian cancer. They concluded
that treatment with ovulation-inducing drugs did not appear to increase the risk for ovarian …

… our data regarding the risk factors for breast cancer in this study. However, our results
indicated that treatment with ovulation induction drugs is not related to breast cancer risk, a result …

… to be independently associated with endometrial cancer controlling for age, European–…
of ovulation induction agents, including clomiphene citrate, are associated with a higher risk of …

… The lack of a convincing association between ovulation-inducing drugs and ovarian
cancer risk in the current study is consistent with the findings from these recent cohort studies. …

… and ovulation induction may increase breast cancer risk, given their association with
lifetime number of ovulatory cycles. Our group previously reported reduced breast cancer risk …

… cancer with some investigations suggesting an increased risk after exposure to ovulation
inducing … A possible trend towards an increased risk has been reported by some authors for …

… breast cancer risk have … for ovulation induction may increase the risk of uterine cancers.
More large well-designed studies are still needed to further clarify the effects on cancer risk of …